Overview

Two Dose Epidural Morphine for Post-cesarean Analgesia

Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that administration of a second dose of epidural morphine 3 mg, 24 hours after an initial intraoperative dose, will provide superior post-cesarean analgesia during the 2nd 24 hours after surgery, compared to a single epidural morphine dose regimen. The primary outcome will be the amount of intravenous morphine patients self-administer during the 2nd 24 hours post-surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Columbia University
Treatments:
Morphine